You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 12, December 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Evaluation of Naloxone for Therapy of Escherichia coli Shock

Species Differences

Lerner B. Hinshaw, PhD; Beverly K. Beller; Alvin C. K. Chang; Dayl J. Flournoy, PhD; Robert A. Lahti, PhD; Richard B. Passey, PhD; Linda T. Archer, PhD

Arch Surg. 1984;119(12):1410-1418.


Abstract

• Dogs and baboons were infused intravenously (IV) with Escherichia coli and treated with the opiate antagonist, naloxone hydrochloride, and the antibiotic, gentamicin sulfate, to determine the therapeutic efficacy of naloxone. Naloxone hydrochloride (2 mg/kg) was injected IV when one fourth of the E coli had been Infused and then infused at 2 mg/kg/hr (six hours for dogs and 12 hours for baboons). Four of five naloxone-treated dogs survived permanently (greater than seven days), while all dogs that were given only E coli died. Arterial BP, blood glucose levels, Pco2, and Po2 were supported at higher levels and lesions of the gastrointestinal tract were prevented In naloxone-treated dogs. A steady decline in blood glucose levels after an initial hyperglycemia was observed in naloxone-treated baboons, indications of peripheral vasoconstriction were noted, and all baboons died within 42 hours.

(Arch Surg 1984;119:1410-1418)



Author Affiliations

From the Veterans Administration Medical Center (Drs Hinshaw, Flournoy, and Archer and Ms Beller) and Departments of Physiology and Biophysics (Dr Hinshaw), Surgery (Dr Hinshaw), and Pathology (Drs Flournoy, Passey, and Archer), University of Oklahoma Health Sciences Center, Oklahoma City, and the CNS Disease Research Division of The Upjohn Co (Dr Lahti), Kalamazoo, Mich.


Footnotes

Accepted for publication Aug 7, 1984.

Read before the Sixth Annual Conference on Shock, Grand Teton National Park, Wyo, June 7, 1983, and the Federation of American Societies for Experimental Biology, St Louis, April 2, 1984.

Reprint requests to Research 151-C, VA Medical Center, 921 NE 13th St, Oklahoma City, OK 73104 (Dr Hinshaw).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Naloxone Therapy for Escherichia coli Sepsis in the Baboon
Hinshaw et al.
Arch Surg 1988;123:700-704.
ABSTRACT  

Prevention of Septic Ventilatory Depression With Naloxone
Chuang et al.
Arch Surg 1987;122:940-945.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.